HRP20000415B1 - Kappa receptor opioid peptides - Google Patents

Kappa receptor opioid peptides

Info

Publication number
HRP20000415B1
HRP20000415B1 HR20000415A HRP20000415A HRP20000415B1 HR P20000415 B1 HRP20000415 B1 HR P20000415B1 HR 20000415 A HR20000415 A HR 20000415A HR P20000415 A HRP20000415 A HR P20000415A HR P20000415 B1 HRP20000415 B1 HR P20000415B1
Authority
HR
Croatia
Prior art keywords
opioid peptides
kappa receptor
receptor opioid
kappa
peptides
Prior art date
Application number
HR20000415A
Other languages
English (en)
Inventor
Junien Jean Louis
Pierre J M Riviere
Claudio D Schteingart
Javier Sueiras Diaz
Jerzy A Trojnar
Todd W Vanderah
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HRP20000415A2 publication Critical patent/HRP20000415A2/hr
Publication of HRP20000415B1 publication Critical patent/HRP20000415B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20000415A 1997-12-23 2000-06-20 Kappa receptor opioid peptides HRP20000415B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides

Publications (2)

Publication Number Publication Date
HRP20000415A2 HRP20000415A2 (en) 2000-12-31
HRP20000415B1 true HRP20000415B1 (en) 2004-06-30

Family

ID=25543752

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000415A HRP20000415B1 (en) 1997-12-23 2000-06-20 Kappa receptor opioid peptides

Country Status (33)

Country Link
US (1) US5965701A (xx)
EP (1) EP1042359B1 (xx)
JP (1) JP4275852B2 (xx)
KR (1) KR100629548B1 (xx)
CN (1) CN1154655C (xx)
AR (1) AR014167A1 (xx)
AT (1) ATE301670T1 (xx)
AU (1) AU747806B2 (xx)
BR (2) BR9814499B1 (xx)
CA (1) CA2315878C (xx)
CR (1) CR5936A (xx)
CZ (1) CZ297281B6 (xx)
DE (1) DE69831176T2 (xx)
DK (1) DK1042359T3 (xx)
EE (1) EE04440B1 (xx)
ES (1) ES2247735T3 (xx)
HK (1) HK1029349A1 (xx)
HR (1) HRP20000415B1 (xx)
HU (1) HU227640B1 (xx)
IL (3) IL136742A0 (xx)
MY (1) MY117542A (xx)
NO (1) NO327080B1 (xx)
NZ (1) NZ505183A (xx)
PL (1) PL195842B1 (xx)
PT (1) PT1042359E (xx)
RU (1) RU2217437C2 (xx)
SK (1) SK286135B6 (xx)
TR (1) TR200001985T2 (xx)
TW (1) TW580502B (xx)
UA (1) UA68366C2 (xx)
UY (1) UY25327A1 (xx)
WO (1) WO1999032510A1 (xx)
ZA (1) ZA9811801B (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
EP1402899A4 (en) * 2001-05-08 2009-03-11 Toray Industries MEANS FOR THE TREATMENT OF SEPSIS
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CN101027057B (zh) 2004-08-23 2017-04-12 曼金德公司 用于药物输送的二酮哌嗪盐、二酮吗啉盐或二酮二氧杂环己烷盐
DK1937219T3 (en) 2005-09-14 2016-02-15 Mannkind Corp A method for drug formulation based on increasing the affinity of the crystalline surfaces of the microparticle of active principles
IN2015DN00888A (xx) 2006-02-22 2015-07-10 Mannkind Corp
US20100029575A1 (en) * 2006-05-26 2010-02-04 Jean-Louis Junien N-Oxides of Kappa Receptor Peptides
WO2007139826A2 (en) * 2006-05-26 2007-12-06 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
NZ577107A (en) 2006-11-10 2012-01-12 Cara Therapeutics Inc Synthetic peptide amide ligands of the kappa opiod receptor
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
WO2008077194A1 (en) * 2006-12-22 2008-07-03 Xenome Ltd Receptor agonists
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
AU2009257311B2 (en) 2008-06-13 2014-12-04 Mannkind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN102065942B (zh) 2008-06-20 2013-12-11 曼金德公司 用于对吸入工作进行实时描绘的交互式设备和方法
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
KR102499439B1 (ko) 2013-03-15 2023-02-13 맨카인드 코포레이션 미세결정성 디케토피페라진 조성물 및 방법
KR102465025B1 (ko) 2013-07-18 2022-11-09 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
CN105517607A (zh) 2013-08-05 2016-04-20 曼金德公司 吹入设备和方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
KR102303092B1 (ko) * 2014-06-26 2021-09-15 마루이시세이야쿠가부시키가이샤 합성 펜타펩티드의 제조법
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10550150B2 (en) * 2015-05-11 2020-02-04 Cadila Healthcare Limited Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
EP3521301B1 (en) * 2016-09-27 2024-03-06 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Polyamide compound and use thereof
TWI712615B (zh) 2017-07-21 2020-12-11 大陸商四川海思科製藥有限公司 肽醯胺類化合物、其製備方法及醫藥用途
TWI717664B (zh) 2017-12-06 2021-02-01 大陸商江蘇恒瑞醫藥股份有限公司 一種苯基丙醯胺類衍生物的鹽及其製備方法
KR20210010490A (ko) 2018-05-16 2021-01-27 지앙수 헨그루이 메디슨 컴퍼니 리미티드 Kor 수용체 작용제의 약학적 조성물
CN114127085B (zh) * 2019-07-25 2024-08-13 西藏海思科制药有限公司 一种肽酰胺盐及其制备方法和在医药上的用途
WO2021013086A1 (zh) * 2019-07-25 2021-01-28 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
CN114615976A (zh) * 2019-08-07 2022-06-10 人福医药美国公司 κ阿片受体肽酰胺激动剂
JP7577265B2 (ja) 2020-06-25 2024-11-05 ヒューマンウェル ファーマシューティカル ユーエス，インコーポレイテッド 医学的障害の治療のためのペプチド
TW202317533A (zh) 2021-07-02 2023-05-01 美商雅斯治療公司 奧沙奈坦(osanetant)之固體形式

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
MY117542A (en) 2004-07-31
CA2315878C (en) 2010-11-16
WO1999032510A9 (en) 1999-09-23
EE200000370A (et) 2001-10-15
CN1154655C (zh) 2004-06-23
CZ297281B6 (cs) 2006-10-11
HUP0100626A2 (hu) 2001-08-28
TW580502B (en) 2004-03-21
BR9814499A (pt) 2000-10-10
WO1999032510A1 (en) 1999-07-01
PL341308A1 (en) 2001-04-09
SK9602000A3 (en) 2001-01-18
NO20003245D0 (no) 2000-06-21
HUP0100626A3 (en) 2001-12-28
UA68366C2 (en) 2004-08-16
CN1283201A (zh) 2001-02-07
HU227640B1 (en) 2011-10-28
JP2001526295A (ja) 2001-12-18
DE69831176T2 (de) 2006-04-20
ZA9811801B (en) 1999-06-22
PT1042359E (pt) 2005-11-30
ATE301670T1 (de) 2005-08-15
BRPI9814499B1 (pt) 2014-10-21
EE04440B1 (et) 2005-02-15
SK286135B6 (sk) 2008-04-07
PL195842B1 (pl) 2007-10-31
IL178471A0 (en) 2007-02-11
HRP20000415A2 (en) 2000-12-31
DE69831176D1 (de) 2005-09-15
NO327080B1 (no) 2009-04-20
JP4275852B2 (ja) 2009-06-10
IL136742A (en) 2006-12-31
RU2217437C2 (ru) 2003-11-27
BRPI9814499B8 (pt) 2021-11-09
AR014167A1 (es) 2001-02-07
AU747806B2 (en) 2002-05-23
BRPI9814499A (pt) 2000-10-10
US5965701A (en) 1999-10-12
AU1940299A (en) 1999-07-12
KR20010033450A (ko) 2001-04-25
EP1042359A1 (en) 2000-10-11
ES2247735T3 (es) 2006-03-01
TR200001985T2 (tr) 2000-11-21
CR5936A (es) 2006-08-18
IL136742A0 (en) 2001-06-14
EP1042359B1 (en) 2005-08-10
CZ20002382A3 (cs) 2000-12-13
NO20003245L (no) 2000-08-23
CA2315878A1 (en) 1999-07-01
KR100629548B1 (ko) 2006-09-27
DK1042359T3 (da) 2005-11-28
HK1029349A1 (en) 2001-03-30
BR9814499B1 (pt) 2014-10-21
NZ505183A (en) 2001-09-28
UY25327A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
ZA9811801B (en) Kappa receptor opioid peptides
IL123258A0 (en) Opioid peptides
AU6868398A (en) Mu-opiate receptor peptides
PL344341A1 (en) Peptides
IL112903A0 (en) GnRH antagonist peptides
EP1007563A4 (en) HM74A RECEPTOR
TW345977U (en) Improved structure for nozzle
GB9718110D0 (en) Peptides
ZA98256B (en) Tachykinin antagonists
HUP0003396A3 (en) Somatostatin antagonist peptides
GB9700154D0 (en) Peptides
GB9812675D0 (en) Peptides
IL114046A0 (en) New opioid peptide antagonists
SI1042359T1 (sl) Kappa receptorski opioidni peptidi
GB9827016D0 (en) Receptor protein
IL113441A0 (en) Opioid peptide analoog
GB9807890D0 (en) Peptides
ZA983615B (en) Kappa opioid agonists
GB9704857D0 (en) Accomodation
GB9701024D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9713146D0 (en) Peptides
GB9717431D0 (en) Peptide synthesis
CA81622S (en) Seat cover dispenser
ZA966434B (en) Novel opioid peptides.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: CARA THERAPEUTICS, INC., US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20111213

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20121223